PMCF Study for COSEAL® in Gynecologic Surgery

Last updated: July 31, 2025
Sponsor: Baxter Healthcare Corporation
Overall Status: Completed

Phase

N/A

Condition

N/A

Treatment

Coseal

Clinical Study ID

NCT05996809
BXU571781
  • Ages > 18
  • Female

Study Summary

The study is a single-arm, retrospective, chart review with a patient questionnaire intended to supplement the patient chart, when necessary. The population will consist of patients who underwent an index gynecologic surgery (performed at least 2 years prior to the start of the study) during which COSEAL was used as an adjunct to good surgical technique to reduce the incidence, severity, and extent of post-surgical adhesion formation. The purpose of the study is to detect the incidence of adhesion-related morbidities as measured by the proportion of adhesion-related readmissions, including reoperations in these patients.

Patient charts will be reviewed to collect the data on readmissions related to adhesions, If the patient chart has no record of adhesion related readmission within approximately 2 years of the index surgery, then a patient questionnaire will be sent. A questionnaire may still be sent if a patient chart has a record of adhesion related readmission within approximately 2 years of the index surgery and further clarification is needed. The questionnaire will collect information regarding readmission or reoperation directly or possibly related to adhesions following the index gynecologic surgical procedure at a hospital or outpatient clinic other than that of the index surgery.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Adult female patients who, at the time of surgery, were ≥18 years of age and whohave undergone an index gynecologic surgery at least 2 years prior to the start ofthe study.

  2. Patients in whom COSEAL was used for the reduction of post-surgical adhesionformation

Exclusion

Exclusion Criteria:

  1. Patients who had frank infection in the abdominopelvic cavity at the time of thesurgery

Study Design

Total Participants: 200
Treatment Group(s): 1
Primary Treatment: Coseal
Phase:
Study Start date:
June 03, 2024
Estimated Completion Date:
May 08, 2025

Connect with a study center

  • Universita Campus Bio Medico di Roma

    Rome, 00128
    Italy

    Site Not Available

  • Feinberg School of Medicine

    Chicago, Illinois 60611
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.